Home / World / World Lifestyle / Archive by category Health & Medical

Archive by category Health & Medical

Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW171 in Advanced Mesothelin-Expressing Cancers

Global Phase 1 clinical trial will evaluate the safety and tolerability of ZW171 in treatment of ovarian cancer, non-small cell lung cancer (NSCLC), and other mesothelin (MSLN) expressing cancers VANCOUVER, British Columbia, Oct. 21, 2024 (Korea Bizwire) – Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to [...]

AskBio Announces 11 Presentations at the European Society of Gene and Cell Therapy 31st Annual Meeting 2024

Research Triangle Park, N.C., Oct. 17, 2024 (Korea Bizwire) – Two oral presentations and nine poster presentations will highlight exciting progress in AskBio’s clinical and pre-clinical pipeline and advancements in the company’s manufacturing technologies Alongside recent clinical program milestones, presentations demonstrate AskBio’s commitment to advancing end-to-end capabilities and goal of delivering breakthrough therapies Asklepios BioPharmaceutical, [...]

Bright Peak Therapeutics Announces Dosing of First Patient in Phase 1/2a Clinical Trial of BPT567, a First-in-Class Bifunctional PD1-IL18 Immunoconjugate

– BPT567 is the first bifunctional PD1-IL18 immunoconjugate to enter clinical development – – Phase 1/2a study will evaluate BPT567 in patients with locally advanced/unresectable or metastatic solid tumors – BASEL, Switzerland and SAN DIEGO, Oct. 17, 2024 (Korea Bizwire) – Bright Peak Therapeutics, a clinical-stage biotechnology company focused on discovering and developing multifunctional immunotherapies [...]

Fortrea Releases Inaugural Corporate Social Responsibility Report

DURHAM, N.C., Oct. 17, 2024 (Korea Bizwire) – Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced the release of the company’s inaugural Corporate Social Responsibility report, “Fortrea for Better.” Available for download on Fortrea.com, the report describes Fortrea’s environmental, social and governance (ESG) activities, reported across four distinct sections: Fortrea for Life: Responsible Environmental Practices [...]

Capsa Healthcare Announces New Interface to EMIS ProScript Connect for RoboWall Prescription Pickup Efficiency

A Media Snippet accompanying this announcement is available by clicking on this link. COLUMBUS, Ohio, Oct. 17, 2024 (Korea Bizwire) – Capsa Healthcare, a leading provider of central fill and medication management solutions, today announced the new, seamless integration of its RoboWall prescription retrieval kiosk system with EMIS ProScript Connect, a leading United Kingdom pharmacy patient medication [...]

Astec acquires AI fertility product Life Whisperer

FUKUOKA, Japan, Oct. 17, 2024 (Korea Bizwire) – Astec, a global manufacturer of medical equipment for assisted reproduction, has acquired Life Whisperer, a non-invasive and rapid embryo and egg (oocyte) assessment tool designed to improve pregnancy outcomes for IVF patients. Life Whisperer comprises three AI algorithms. Life Whisperer Viability assesses images of embryos to determine [...]

RENASYS™ EDGE Negative Pressure Wound Therapy System wins Red Dot Award for Design

Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, is proud to announce that its RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System has won the Red Dot Award for Design Concept 2024 in the Medical Devices and Technology Category, recognizing its intuitive pairing of NPWT housed in a patient-friendly design. The Red Dot Awards [...]

Junshi Biosciences Announces Toripalimab Obtained Approval for Marketing in India and China’s Hong Kong SAR

SHANGHAI, Oct. 15, 2024 (Korea Bizwire) – Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, and its wholly-owned subsidiary, TopAlliance Biosciences Inc. (TopAlliance Biosciences), announce that toripalimab (Indian trade name: ZYTORVI®, Hong Kong trade name: LOQTORZI®) has [...]

Boehringer Ingelheim and WHO Foundation join forces to promote equitable access to healthcare and increase efforts for suicide prevention

Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to advance access to quality healthcare services for all, with a special focus on vulnerable populations in the Americas who are at greater risk of suicide. Through this partnership with the WHO Foundation, [...]

Ardena Signs Agreement to Expand US Footprint with the Acquisition of Advanced Drug Product Manufacturing Facility from Catalent

Ghent, Belgium, Oct. 14, 2024 (Korea Bizwire) – Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with GMP facilities in Belgium, Spain, the Netherlands and Sweden, today announced it has signed a definitive agreement to acquire Catalent’s state-of-the-art facility in Somerset, New Jersey. This acquisition will significantly enhance Ardena’s capabilities in downstream late-stage [...]